314 related articles for article (PubMed ID: 9442442)
1. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
[TBL] [Abstract][Full Text] [Related]
3. [The molecular genetic analysis of polycystic kidney disease].
Fukuda Y
Nihon Rinsho; 1992 Dec; 50(12):3093-9. PubMed ID: 1283420
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.
Saini AK; Saini R; Singh S
Mol Med; 2020 Dec; 26(1):128. PubMed ID: 33308138
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of autosomal dominant polycystic kidney disease type 1 and hereditary renal hypouricemia type 2: A model of early-onset and fast cyst progression.
Peces R; Mena R; Peces C; Cuesta E; Selgas R; Barruz P; Lapunzina P; Nevado J
Clin Genet; 2020 Jun; 97(6):857-868. PubMed ID: 32166738
[TBL] [Abstract][Full Text] [Related]
6. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
[TBL] [Abstract][Full Text] [Related]
7. The polycystins: a novel class of membrane-associated proteins involved in renal cystic disease.
Sandford R; Mulroy S; Foggensteiner L
Cell Mol Life Sci; 1999 Nov; 56(7-8):567-79. PubMed ID: 11212307
[TBL] [Abstract][Full Text] [Related]
8. Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Delbarba E; Econimo L; Dordoni C; Martin E; Mazza C; Savoldi G; Alberici F; Scolari F; Izzi C
J Nephrol; 2022 Mar; 35(2):645-652. PubMed ID: 34357571
[TBL] [Abstract][Full Text] [Related]
9. Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.
Peces R; Mena R; Martín Y; Hernández C; Peces C; Tellería D; Cuesta E; Selgas R; Lapunzina P; Nevado J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1321. PubMed ID: 32533764
[TBL] [Abstract][Full Text] [Related]
10. A single-center analysis of genotype-phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing.
Yan Z; Wang Y; Deng W; Zhou Y; Hu Y; Qi K; Liu D; Xia R; Liu R; Zeng W; Zhang W; Xu J; Xiong F; Miao Y
Front Genet; 2022; 13():934463. PubMed ID: 36186434
[No Abstract] [Full Text] [Related]
11. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
Kurbegovic A; Trudel M
Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
[TBL] [Abstract][Full Text] [Related]
12. Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment.
Reiterová J; Tesař V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328738
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease.
Kim Y; Park HC; Ryu H; Kim YC; Ahn C; Lee KB; Kim YH; Han S; Bae EH; Jeong K; Choi J; Oh KH; Oh YK
J Korean Med Sci; 2023 Sep; 38(38):e296. PubMed ID: 37750370
[TBL] [Abstract][Full Text] [Related]
14. Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy?
Ponticelli C; Moroni G; Reggiani F
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834113
[TBL] [Abstract][Full Text] [Related]
15. Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease.
Zhang JQJ; Saravanabavan S; Chandra AN; Munt A; Wong ATY; Harris PC; Harris DCH; McKenzie P; Wang Y; Rangan GK
Am J Pathol; 2021 May; 191(5):902-920. PubMed ID: 33549515
[TBL] [Abstract][Full Text] [Related]
16. Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease.
Casarella A; Nicotera R; Zicarelli MT; Urso A; Presta P; Deodato F; Bolignano D; De Sarro G; Andreucci M; Russo E; Coppolino G
Med Res Rev; 2022 Jan; 42(1):629-640. PubMed ID: 34328226
[TBL] [Abstract][Full Text] [Related]
17. Variation in age at ESRD in autosomal dominant polycystic kidney disease.
Reed BY; McFann K; Bekheirnia MR; Nobakhthaghighi N; Masoumi A; Johnson AM; Shamshirsaz AA; Kelleher CL; Schrier RW
Am J Kidney Dis; 2008 Feb; 51(2):173-83. PubMed ID: 18215695
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic advances in ADPKD: the future awaits.
Capuano I; Buonanno P; Riccio E; Amicone M; Pisani A
J Nephrol; 2022 Mar; 35(2):397-415. PubMed ID: 34009558
[TBL] [Abstract][Full Text] [Related]
19. Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.
Leonhard WN; Happe H; Peters DJ
J Am Soc Nephrol; 2016 Dec; 27(12):3530-3538. PubMed ID: 27493259
[TBL] [Abstract][Full Text] [Related]
20. Monoallelic pathogenic
Dordoni C; Zeni L; Toso D; Mazza C; Mescia F; Cortinovis R; Econimo L; Savoldi G; Alberici F; Scolari F; Izzi C
Clin Kidney J; 2024 Feb; 17(2):sfae026. PubMed ID: 38404363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
